CR Bard Picks Up Bellwether Win In Vein Filter Defect Suit

Law360, New York (June 07, 2012, 8:03 PM ET) -- An Arizona state jury has found that a C.R. Bard Inc. vein filter is not defective and that the company did not act negligently, the medical giant said Thursday, handing it a decisive victory in the first of the suits over the device to go to trial.

Plaintiff Rosemary Everett claimed in a consolidated action that Bard's first-generation Interior Vena Cava Recovery Filter System was prone to failure. She was implanted with the device, used to prevent blood clots caused by surgery, and in less than...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required